Dr. Robert Segal is Board Certified Internist/ Nephrologist with more than 20 years of broad experience in drug/device development, global clinical research, regulatory strategy/authority interaction, government funding and scientific affairs. He is thorough familiarity with aspects related to intellectual property and orphan drug/fast track applications. He has received Federal and Biodefense funding and contracts, including five NIH SBIR (Small Business Innovative Research) grants/contracts worth around $10 Million.
Dr. Segal holds an active MD license in Pennsylvania and previously got licensed in Maryland, California, the UK and South Africa.